Wenbing Liu
- Building and Construction top 10%
- Building Energy and Comfort Optimization 2
-
- Infection Control and Ventilation 2
- Modeling and Simulation top 10%
- Urology top 10%
-
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 2
-
- Immune Cell Function and Interaction 3
-
- RNA modifications and cancer 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Chunwen XuLi LiuPeter V. NielsenYi WangHaijian ZhouTian QinHongyu RenChen Liu
- Journals
- SHILAP Revista de lepidopterología (2 papers)Brain Research (1 paper)Free Radical Biology and Medicine (1 paper)
In The Last Decade
Wenbing Liu
20 papers receiving 412 citations
Peers
Comparison fields: 5 of 93
- Molecular Medicine 33
- Building and Construction 70
- Pulmonary and Respiratory Medicine 161
- Modeling and Simulation 21
- Urology 29
Countries citing papers authored by Wenbing Liu
This map shows the geographic impact of Wenbing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbing Liu more than expected).
Fields of papers citing papers by Wenbing Liu
This network shows the impact of papers produced by Wenbing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbing Liu. The network helps show where Wenbing Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenbing Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 50 | |
| 15 | 2021 | 24 | |
| 16 | 2021 | 42 | |
| 17 | 2020 | 78 | |
| 18 | 2017 | 48 | |
| 19 | 2007 | 18 | |
| 20 | Progress in Breeding of Nude Hybrid Rice | 2005 | 4 |
About Wenbing Liu
Wenbing Liu is a scholar working on Hematology, Modeling and Simulation and Molecular Medicine, having authored 24 papers that have together received 421 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Immune Cell Function and Interaction (3 papers), Building Energy and Comfort Optimization (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), RNA modifications and cancer (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Infection Control and Ventilation (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Molecular Medicine (33 citations), Building and Construction (70 citations) and Pulmonary and Respiratory Medicine (161 citations). Wenbing Liu has collaborated with scholars based in China, Denmark and France. Frequent co-authors include Chunwen Xu, Li Liu, Peter V. Nielsen, Yi Wang, Haijian Zhou, Tian Qin, Hongyu Ren, Chen Liu, Susu He and Chen Huang. Their work appears in journals such as SHILAP Revista de lepidopterología, Brain Research and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.